A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Board of Governors of the Federal Reserve System relating to "Revisions to the Large Financial Institution Rating System and Framework for the Supervision of Insurance Organizations".
Sponsor
Full profile: /officials/W000817
Source: Congress.gov · FEC
Cosponsors (0)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
2026-03-04
Source: Congress.gov
Plain-English Summary
Congress is considering blocking a new Federal Reserve rule that would change how large banks and insurance companies are rated and supervised. If approved, this resolution would reject the Fed's updated system for evaluating the safety and soundness of major financial institutions. The measure would affect large banks and insurance organizations that are currently subject to Federal Reserve oversight.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S4648A bill to improve transparency with respect to foreign influence on Department of Defense contractors.Referred to Committee · 2026-06-01
- S4550Maternal Health Pandemic Response ActReferred to Committee · 2026-05-18
- SRES732A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.Referred to Committee · 2026-05-14
- S4509PBM ActReferred to Committee · 2026-05-13